Galmed Pharmaceuticals Ltd (GLMD)
US$ 2.2599-1.31%
Price Chart
Key Statistics
Market Cap
$ 2.69M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
104.79K
52W High
$ 15.10
52W Low
$ 1.15
Dividend Yield
0.00%
Beta
0.49
Technicals
50-Day MA
1.5606
200-Day MA
3.0605
52 Week High
15.1
52 Week Low
1.15
About GLMD
Galmed Pharmaceuticals Ltd., a biopharmaceutical company, focuses on the development of Aramchol for the treatment of liver diseases.
Employees
3
Headquarters
Ramat Gan, Israel
CEO
Mr. Allen Baharaff
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg